We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)
Article purchase
Temporarily unavailable
References
1
Addington, DE, Toews, JA, Addington, JM. Risperidone and tardive dyskinesiaJ Clin Psychiatry1995 ; 56 : 484-5Google ScholarPubMed
Chouinard, G. Effects of risperidone in tardive dyskinesia: an analysis of the Canadian multicenter risperidone studyJ Clin Psychopharmacol1995 ; 15 suppl 1 : 36S–44SCrossRefGoogle ScholarPubMed
4
Coulter, DM, Pillans, PI. Fluoxetine and extrapyramidal side effectsAm J Psychiatry1995 ; 152 : 122-5Google ScholarPubMed
Gardos, G, Cole, JO, Salomon, M, Schniebolk, S. Clinical forms of Severe tardive dyskinesiaAm J Psychiatry1987 ; 144 : 895–902Google ScholarPubMed
7
Kopala, LC, Honer, WG. Schizophrenia and severe tardive dyskinesia responsive to risperidoneJ Clin Psychopharmacol1994 ; 14 : 430-1CrossRefGoogle Scholar
8
Nyberg, S, Farde, L, Eriksson, L, Halldin, C, Eriksson, B. 5-HT2 and D2 dopamine receptor occupancy in the living human brainPsychopharmacology1993 ; 110 : 265-72CrossRefGoogle ScholarPubMed
9
Rangwani, SR, Gupta, S, Burke, WJ, Potter, J. Improvement of debilitating tardive dyskinesia with risperidone. Ann Clin Psychiatry1996 ; 8 : 27-9CrossRefGoogle ScholarPubMed
10
Woerner, MC, Sheitman, BB, Lieberman, JA, Kane, JM. Tardive dyskinesia induced by risperidone?Am J Psychiaty1996 ; 153 : 843Google ScholarPubMed
Comments
No Comments have been published for this article.